Indication
Fabry disease
Fabry disease is a rare, inherited X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene that lead to a deficiency of the enzyme alpha-galactosidase A. Read more about Fabry disease
3 drugs 3 manufacturers
Drugs that treat it
Common Fabry disease therapies.
GALAFOLD (migalastat HCl)
ELFABRIO (pegunigalsidase alfa-iwxj)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonFabry disease is a rare, inherited X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene that lead to a deficiency of the enzyme alpha-galactosidase A.
This enzymatic defect results in progressive intracellular accumulation of globotriaosylceramide and related glycosphingolipids within vascular endothelial cells and visceral tissues throughout the body.
Clinical manifestations typically include episodic neuropathic extremity pain, cutaneous angiokeratomas, hypohidrosis, and corneal verticillata, which often emerge during childhood or adolescence.
If untreated, the condition can progress to life-threatening multisystem complications in adulthood, most notably cardiomyopathy, progressive renal impairment culminating in end-stage kidney disease, and early stroke.
- nih.gov
Fabry disease is a rare, inherited X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene that lead to a deficiency of the enzyme alpha-galactosidase A Fabry disease is a rare, inherited X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene that lead to a deficiency of the enzyme alpha-galactosidase A. This enzymatic defect results in progressive intracellular accumulation of globotriaosylceramide and related glycosphingolipids within vascul...
- rarediseases.org
Fabry disease is a rare, inherited X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene that lead to a deficiency of the enzyme alpha-galactosidase A Fabry disease is a rare, inherited X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene that lead to a deficiency of the enzyme alpha-galactosidase A. This enzymatic defect results in progressive intracellular accumulation of globotriaosylceramide and related glycosphingolipids within vascul...
- nih.gov
Fabry disease is a rare, inherited X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene that lead to a deficiency of the enzyme alpha-galactosidase A. This enzymatic defect results in progressive intracellular accumulation of globotriaosylceramide and related glycosphingolipids within vascular endothelial cells and visceral tissues throughout the body Clinical manifestations typically include episodic neuropathic extremity pain, cutaneous angiokeratomas, hypohidrosis...
- nih.gov
Clinical manifestations typically include episodic neuropathic extremity pain, cutaneous angiokeratomas, hypohidrosis, and corneal verticillata, which often emerge during childhood or adolescence If untreated, the condition can progress to life-threatening multisystem complications in adulthood, most notably cardiomyopathy, progressive renal impairment culminating in end-stage kidney disease, and early stroke
Personalize your experience
Follow Fabry disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.